Heron Therapeutics (HRTX) Other Non Operating Income (2016 - 2025)
Historic Other Non Operating Income for Heron Therapeutics (HRTX) over the last 10 years, with Q3 2025 value amounting to -$11.3 million.
- Heron Therapeutics' Other Non Operating Income fell 280743.59% to -$11.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.6 million, marking a year-over-year decrease of 58936.45%. This contributed to the annual value of $430000.0 for FY2024, which is 2321.43% down from last year.
- Latest data reveals that Heron Therapeutics reported Other Non Operating Income of -$11.3 million as of Q3 2025, which was down 280743.59% from -$744000.0 recorded in Q2 2025.
- Heron Therapeutics' Other Non Operating Income's 5-year high stood at $2.0 million during Q4 2024, with a 5-year trough of -$11.3 million in Q3 2025.
- Its 5-year average for Other Non Operating Income is -$1.1 million, with a median of -$445000.0 in 2021.
- As far as peak fluctuations go, Heron Therapeutics' Other Non Operating Income soared by 45525.42% in 2024, and later plummeted by 280743.59% in 2025.
- Over the past 5 years, Heron Therapeutics' Other Non Operating Income (Quarter) stood at $868000.0 in 2021, then soared by 52.3% to $1.3 million in 2022, then tumbled by 105.98% to -$79000.0 in 2023, then skyrocketed by 2596.2% to $2.0 million in 2024, then tumbled by 675.0% to -$11.3 million in 2025.
- Its Other Non Operating Income was -$11.3 million in Q3 2025, compared to -$744000.0 in Q2 2025 and -$519000.0 in Q1 2025.